January 13, 2020
January 13, 2020 —
University of California San Diego School of Medicine researchers identified how THC from marijuana accelerates cancer growth in patients with human papillomavirus (HPV)-positive head and neck cancer.
January 6, 2020
January 6, 2020 —
San Diego Zoo Safari Park and UC San Diego Health experts performed cataract surgery to restore a 3-year-old gorilla’s eyesight.
December 16, 2019
December 16, 2019 —
University of California San Diego School of Medicine and Moores Cancer Center researchers developed a math equation to predict and detect liver cancer and identified when healthy cells become cancerous.
October 21, 2019
October 21, 2019 —
J. Silvio Gutkind elected to National Academy of Medicine for his contributions to the understanding of cancer signaling networks and pioneering the study of the PIK3CA-mTOR signaling circuitry in head and neck cancer.
October 17, 2019
October 17, 2019 —
New Precision Immunotherapy Therapy clinic at Moores Cancer Center at UC San Diego Health matches patients using genetic profiling to personalized cancer treatment plans.
September 24, 2019
September 24, 2019 —
University of California San Diego School of Medicine researchers have identified a switch controlling HIV reproduction in immune cells which can eliminate dormant HIV reservoirs.
September 20, 2019
September 20, 2019 —
Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego researchers describe new use of leukemia drug, nilotinib, to treat subtype of medulloblastoma, a deadly pediatric brain cancer.
September 5, 2019
September 5, 2019 —
The San Diego Center for AIDS Research (CFAR) at University of California San Diego has been awarded planning grants to help the federal government achieve its goal of reducing the number of new HIV infections in the United States by 90 percent by 2030.
September 3, 2019
September 3, 2019 —
A new University of California San Diego School of Medicine study links changes in the gene for the protein focal adhesion kinase, or FAK, to ovarian cancer’s ability to survive chemotherapy.
August 21, 2019
August 21, 2019 —
University of California San Diego School of Medicine researchers identified a new therapeutic approach in mouse models that halts drug resistance and cancer progression by using an antibody that induces the immune system via macrophages to seek and kill cancer cells.
